Jacques Friborg

2.8k total citations · 1 hit paper
41 papers, 2.1k citations indexed

About

Jacques Friborg is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Jacques Friborg has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 13 papers in Epidemiology and 11 papers in Virology. Recurrent topics in Jacques Friborg's work include HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (11 papers) and Hepatitis C virus research (11 papers). Jacques Friborg is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (11 papers) and Hepatitis C virus research (11 papers). Jacques Friborg collaborates with scholars based in United States, Canada and Germany. Jacques Friborg's co-authors include Michael O. Hottiger, Wing‐Pui Kong, Richard J. Colonno, Éric A. Cohen, Gary J. Nabel, Wing-Pui Kong, Fiona McPhee, S Carrière, Ronald E. Rose and Kimberly E. Foreman and has published in prestigious journals such as Nature, New England Journal of Medicine and PLoS ONE.

In The Last Decade

Jacques Friborg

40 papers receiving 2.0k citations

Hit Papers

p53 inhibition by the LANA protein of KSHV protects again... 1999 2026 2008 2017 1999 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. p53 inhibition by the LANA protein of KSHV protects against cell death
    1999 573 citations Jacques Friborg, Wing‐Pui Kong et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Friborg United States 22 882 773 763 619 330 41 2.1k
Roberto Bugarini Italy 23 817 0.9× 649 0.8× 626 0.8× 278 0.4× 371 1.1× 44 2.4k
Joaquin Valdes United States 16 453 0.5× 191 0.2× 1.1k 1.4× 887 1.4× 134 0.4× 31 2.6k
Jean Marie Arduino United States 18 490 0.6× 245 0.3× 614 0.8× 433 0.7× 523 1.6× 37 1.8k
Chiara Agrati Italy 31 671 0.8× 407 0.5× 872 1.1× 326 0.5× 397 1.2× 141 2.8k
Rui M. M. Victorino Portugal 25 544 0.6× 247 0.3× 422 0.6× 1.1k 1.7× 203 0.6× 102 2.6k
Ping An United States 31 755 0.9× 224 0.3× 550 0.7× 750 1.2× 701 2.1× 76 2.5k
Daniel M. Jones United States 25 569 0.6× 370 0.5× 614 0.8× 141 0.2× 1.4k 4.2× 71 3.3k
Fayez M. Hamzeh United States 22 986 1.1× 482 0.6× 388 0.5× 184 0.3× 191 0.6× 42 1.7k
Megan Wind‐Rotolo United States 29 1.1k 1.3× 824 1.1× 845 1.1× 736 1.2× 462 1.4× 87 3.1k
Shuguang Chen China 27 344 0.4× 259 0.3× 640 0.8× 407 0.7× 587 1.8× 83 2.3k

Countries citing papers authored by Jacques Friborg

Since Specialization
Citations

This map shows the geographic impact of Jacques Friborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Friborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Friborg more than expected).

Fields of papers citing papers by Jacques Friborg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Friborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Friborg. The network helps show where Jacques Friborg may publish in the future.

Co-authorship network of co-authors of Jacques Friborg

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Friborg. A scholar is included among the top collaborators of Jacques Friborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Friborg. Jacques Friborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hiebert, Sheldon, Jacques Friborg, Fei Yu, et al.. (2017). The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease. Bioorganic & Medicinal Chemistry Letters. 28(1). 43–48. 8 indexed citations
2.
Chen, Jie, Qian Zhao, Li‐Qiang Sun, et al.. (2016). Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 27(3). 590–596. 5 indexed citations
3.
4.
McPhee, Fiona, et al.. (2014). Endogenous IFNλ in Viral Hepatitis Patients. Journal of Interferon & Cytokine Research. 34(7). 552–556. 7 indexed citations
5.
Friborg, Jacques, Nannan Zhou, Xiaoyan Yang, et al.. (2014). In Vitro Assessment of Re-treatment Options for Patients with Hepatitis C Virus Genotype 1b Infection Resistant to Daclatasvir Plus Asunaprevir. Infectious Diseases and Therapy. 4(1). 137–144. 18 indexed citations
6.
7.
Friborg, Jacques, et al.. (2013). Isolation and characterization of interferon lambda-resistant hepatitis C virus replicon cell lines. Virology. 444(1-2). 384–393. 2 indexed citations
8.
McPhee, Fiona, Jacques Friborg, Steven M. LeVine, et al.. (2012). Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir. Antimicrobial Agents and Chemotherapy. 56(7). 3670–3681. 86 indexed citations
9.
McPhee, Fiona, Amy K. Sheaffer, Jacques Friborg, et al.. (2012). Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032). Antimicrobial Agents and Chemotherapy. 56(10). 5387–5396. 139 indexed citations
10.
Sheaffer, Amy K., Min S. Lee, Dennis Hernandez, et al.. (2011). Development of a Chimeric Replicon System for Phenotypic Analysis of Ns3 Protease Sequences from HCV Clinical Isolates. Antiviral Therapy. 16(5). 705–718. 13 indexed citations
11.
Friborg, Jacques, et al.. (1999). p53 inhibition by the LANA protein of KSHV protects against cell death. Nature. 402(6764). 889–894. 573 indexed citations breakdown →
12.
Blais, Charles, Jean‐Lucien Rouleau, Nancy J. Brown, et al.. (1999). Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology. 43(2-3). 293–302. 66 indexed citations
13.
Coady, Michael J., et al.. (1998). Effects of Vpu Expression onXenopusOocyte Membrane Conductance. Virology. 244(1). 39–49. 39 indexed citations
14.
Friborg, Jacques, et al.. (1998). Structural and Functional Analysis of the Membrane-Spanning Domain of the Human Immunodeficiency Virus Type 1 Vpu Protein. Virology. 251(1). 96–107. 55 indexed citations
15.
Friborg, Jacques, Wing-Pui Kong, C. Clay Flowers, et al.. (1998). Distinct Biology of Kaposi’s Sarcoma-Associated Herpesvirus from Primary Lesions and Body Cavity Lymphomas. Journal of Virology. 72(12). 10073–10082. 28 indexed citations
16.
Foreman, Kimberly E., Jacques Friborg, Wing-Pui Kong, et al.. (1997). Propagation of a Human Herpesvirus from AIDS-Associated Kaposi's Sarcoma. New England Journal of Medicine. 336(3). 163–171. 139 indexed citations
17.
18.
Friborg, Jacques, et al.. (1994). Mutational analysis of the HIV-1 Vpu protein.. PubMed. 8 Suppl 1. S156–62. 3 indexed citations
19.
Fournier, Michel, et al.. (1992). Limited immunotoxic potential of technical formulation of the herbicide atrazine (AAtrex) in mice. Toxicology Letters. 60(3). 263–274. 44 indexed citations
20.
Dandavino, R, C Beaudry, S Carrière, et al.. (1982). Cadaver kidney transplantation: a retrospective comparison of two immunosuppressive regimens.. PubMed. 14(4). 635–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Bugarini Breakdown of academic impact, for papers by Joaquin Valdes Breakdown of academic impact, for papers by Jean Marie Arduino Breakdown of academic impact, for papers by Chiara Agrati Breakdown of academic impact, for papers by Rui M. M. Victorino Breakdown of academic impact, for papers by Ping An Breakdown of academic impact, for papers by Daniel M. Jones Breakdown of academic impact, for papers by Fayez M. Hamzeh Breakdown of academic impact, for papers by Megan Wind‐Rotolo Breakdown of academic impact, for papers by Shuguang Chen
Rankless by CCL
2026